DK175538B1 - Fremgangsmåde til fremstilling af et alfa-amiderende enzym, genmanipuleret mikroorganisme eller værtscelle og rekombinant DNA-molekyle,............. - Google Patents
Fremgangsmåde til fremstilling af et alfa-amiderende enzym, genmanipuleret mikroorganisme eller værtscelle og rekombinant DNA-molekyle,............. Download PDFInfo
- Publication number
- DK175538B1 DK175538B1 DK198804489A DK448988A DK175538B1 DK 175538 B1 DK175538 B1 DK 175538B1 DK 198804489 A DK198804489 A DK 198804489A DK 448988 A DK448988 A DK 448988A DK 175538 B1 DK175538 B1 DK 175538B1
- Authority
- DK
- Denmark
- Prior art keywords
- enzyme
- amidating
- sequence
- activity
- host cell
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/67—General methods for enhancing the expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y114/00—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14)
- C12Y114/17—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14) with reduced ascorbate as one donor, and incorporation of one atom of oxygen (1.14.17)
- C12Y114/17003—Peptidylglycine monooxygenase (1.14.17.3)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Endocrinology (AREA)
- Toxicology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Immunology (AREA)
- Enzymes And Modification Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Detergent Compositions (AREA)
- Peptides Or Proteins (AREA)
- Materials Applied To Surfaces To Minimize Adherence Of Mist Or Water (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8616187 | 1987-08-14 | ||
US07/086,161 US6319685B1 (en) | 1984-09-27 | 1987-08-14 | Alpha-amidating enzyme compositions and processes for their production and use |
Publications (3)
Publication Number | Publication Date |
---|---|
DK448988D0 DK448988D0 (da) | 1988-08-11 |
DK448988A DK448988A (da) | 1989-02-15 |
DK175538B1 true DK175538B1 (da) | 2004-11-29 |
Family
ID=22196693
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK198804489A DK175538B1 (da) | 1987-08-14 | 1988-08-11 | Fremgangsmåde til fremstilling af et alfa-amiderende enzym, genmanipuleret mikroorganisme eller værtscelle og rekombinant DNA-molekyle,............. |
Country Status (13)
Country | Link |
---|---|
US (1) | US6319685B1 (fi) |
EP (2) | EP0308067A3 (fi) |
JP (1) | JP2979172B2 (fi) |
KR (1) | KR0136611B1 (fi) |
AT (1) | ATE198355T1 (fi) |
CA (1) | CA1341454C (fi) |
DE (1) | DE3856446T2 (fi) |
DK (1) | DK175538B1 (fi) |
FI (1) | FI883722A (fi) |
HU (3) | HU213227B (fi) |
LT (1) | LT4029B (fi) |
NO (1) | NO883592L (fi) |
RU (2) | RU2080385C1 (fi) |
Families Citing this family (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6319685B1 (en) | 1984-09-27 | 2001-11-20 | Unigene Laboratories, Inc. | Alpha-amidating enzyme compositions and processes for their production and use |
US4708934A (en) * | 1984-09-27 | 1987-11-24 | Unigene Laboratories, Inc. | α-amidation enzyme |
US5789234A (en) * | 1987-08-14 | 1998-08-04 | Unigene Laboratories, Inc. | Expression systems for amidating enzyme |
US5871995A (en) * | 1989-08-15 | 1999-02-16 | Shiseido Company, Ltd. | Purified enzymes participating in C-terminal amidation |
EP0465404B1 (en) * | 1990-06-01 | 1995-11-15 | Ciba-Geigy Ag | Peptdidylhydroxylglycine N-C lyase and DNA coding therefor |
US5580751A (en) * | 1990-09-14 | 1996-12-03 | Carlsberg A/S | Process for the preparation of C-terminally amidated peptides |
DK67691D0 (da) * | 1991-03-01 | 1991-04-15 | Carlbiotech Ltd As | Enzymatisk fremgangsmaade til c-terminal modificering af peptider og mellemprodukter til brug ved fremgangsmaaden |
AU4415796A (en) * | 1994-12-07 | 1996-06-26 | Bionebraska, Inc. | Production of c-terminal amidated peptides from recombinant protein constructs |
US5912014A (en) * | 1996-03-15 | 1999-06-15 | Unigene Laboratories, Inc. | Oral salmon calcitonin pharmaceutical products |
AU742270B2 (en) | 1997-04-16 | 2001-12-20 | Enteris Biopharma, Inc. | Direct expression of peptides into culture media |
JP4483579B2 (ja) | 2002-07-26 | 2010-06-16 | 味の素株式会社 | トリペプチド以上のペプチドの製造方法 |
US8088734B2 (en) | 2003-01-21 | 2012-01-03 | Unigene Laboratories Inc. | Oral delivery of peptides |
US7531518B2 (en) | 2004-05-14 | 2009-05-12 | Unigene Laboratories Inc. | Method for fostering bone formation and preservation |
US7648965B2 (en) * | 2004-05-14 | 2010-01-19 | Unigene Laboratories Inc. | Method for fostering bone formation and preservation |
US20060089723A1 (en) * | 2004-10-25 | 2006-04-27 | Murphy Kieran P | Method for bone augmentation |
US7445911B2 (en) | 2004-11-24 | 2008-11-04 | Unigene Laboratories Inc. | Enzymatic reactions in the presence of keto acids |
PA8660701A1 (es) | 2005-02-04 | 2006-09-22 | Pfizer Prod Inc | Agonistas de pyy y sus usos |
US20060293667A1 (en) * | 2005-05-19 | 2006-12-28 | Agnes Vignery | Bone implant device and methods of using same |
US8377863B2 (en) | 2007-05-29 | 2013-02-19 | Unigene Laboratories Inc. | Peptide pharmaceutical for oral delivery |
AU2010206614B2 (en) | 2009-01-22 | 2015-03-26 | Keybioscience Ag | Treatment for obesity |
MX2012005912A (es) | 2009-11-23 | 2012-10-05 | Amylin Pharmaceuticals Inc | Conjugado de polipeptido. |
TW201138808A (en) | 2010-05-03 | 2011-11-16 | Bristol Myers Squibb Co | Serum albumin binding molecules |
MX345245B (es) | 2010-09-28 | 2017-01-23 | Amylin Pharmaceuticals Llc | Polipeptidos manipulados que tienen duracion de accion incrementada. |
DK3241558T3 (da) | 2010-09-28 | 2021-04-26 | Aegerion Pharmaceuticals Inc | Højopløselige leptiner |
ES2712805T3 (es) | 2011-06-15 | 2019-05-14 | Resother Pharma Aps Næsseslottet | Productos farmacéuticos antiinflamatorios |
JP6040464B2 (ja) | 2011-07-08 | 2016-12-07 | アエゲリオン・ファーマシューティカルズ・インコーポレイテッドAegerion Pharmaceuticals, Inc. | 作用持続期間が増大し、免疫原性が減少した操作されたポリペプチド |
WO2013009545A1 (en) | 2011-07-08 | 2013-01-17 | Amylin Pharmaceuticals, Inc. | Engineered polypeptides having enhanced duration of action with reduced immunogenicity |
EP3357540A1 (en) | 2011-11-02 | 2018-08-08 | KeyBioscience AG | Combination of calcitonin mimetic and insulin sensitizer |
US9533022B2 (en) | 2011-11-02 | 2017-01-03 | KeyBioscience A/S | Peptide analogs for treating diseases and disorders |
AU2012332265B2 (en) | 2011-11-02 | 2016-11-10 | Keybioscience Ag | Peptide analogs for treating diseases and disorders |
PL3068796T3 (pl) | 2013-11-14 | 2018-07-31 | Keybioscience Ag | Mimetyki kalcytoniny do leczenia chorób i zaburzeń |
CN105939759B (zh) | 2013-12-02 | 2020-01-17 | 康德生物医疗技术公司 | 用于治疗白癜风的组合物和方法 |
EP3148565A4 (en) | 2014-05-28 | 2018-06-06 | Stealth Biotherapeutics Corp | Therapeutic compositions including frataxin, lactoferrin, and mitochondrial energy generating enzymes, and uses thereof |
WO2015183988A1 (en) | 2014-05-28 | 2015-12-03 | Stealth Peptides International, Inc. | Therapeutic compositions including therapeutic small molecules and uses thereof |
WO2015195737A1 (en) | 2014-06-17 | 2015-12-23 | Stealth Peptides International, Inc. | Methods of identifying and monitoring mitochondrial dysfunction using monocyte screening |
GB201500263D0 (en) | 2015-01-08 | 2015-02-25 | Keybioscience Ag | Calcitonin analogues for treating diseases and disorders |
AU2016206950B2 (en) | 2015-01-12 | 2021-05-06 | Enteris Biopharma, Inc. | Solid oral dosage forms |
GB201704429D0 (en) | 2017-03-21 | 2017-05-03 | Keybioscience Ag | Calcitonin mimetics for treating diseases and disorders |
GB201707955D0 (en) | 2017-05-18 | 2017-07-05 | Keybioscience Ag | Dual amylin and calcitonin receptor agonists for treating diseases and disorders |
GB201813677D0 (en) | 2018-08-22 | 2018-10-03 | Keybioscience Ag | Calcitonin mimetics for treating diseases and disorders |
GB201813678D0 (en) | 2018-08-22 | 2018-10-03 | Keybioscience Ag | Acylated calcitonin mimetics |
GB202001024D0 (en) | 2020-01-24 | 2020-03-11 | Key Bioscience Ag | Oxyntomodulin mimetics |
WO2022266467A2 (en) | 2021-06-17 | 2022-12-22 | Dana-Farber Cancer Institute, Inc. | Recombinant histone polypeptide and uses thereof |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US655366A (en) | 1900-05-16 | 1900-08-07 | Simeon C Lawlor | Window-cleaner. |
US4518693A (en) * | 1982-11-01 | 1985-05-21 | Research Corporation | Immobilized biocatalysts |
GB2141430B (en) | 1983-06-15 | 1987-01-21 | Kingdon Craig R | Peptides, pharmaceutical compositions, genes, vectors, host organisms, processes for their production and diagnostic reagents |
WO1985000043A1 (en) | 1983-06-15 | 1985-01-03 | Kingdon Craig R | Peptides, pharmaceutical compositions, genes, vectors, host organisms, processes for their production and diagnostic reagents |
US4549986A (en) | 1983-12-23 | 1985-10-29 | The Salk Institute For Biological Studies | Human CGRP |
US4708934A (en) | 1984-09-27 | 1987-11-24 | Unigene Laboratories, Inc. | α-amidation enzyme |
US6319685B1 (en) | 1984-09-27 | 2001-11-20 | Unigene Laboratories, Inc. | Alpha-amidating enzyme compositions and processes for their production and use |
JPS6229997A (ja) | 1985-04-08 | 1987-02-07 | Sankyo Co Ltd | C末端にプロリンアミドを有するペプチドの製法 |
GB8523156D0 (en) | 1985-09-19 | 1985-10-23 | Celltech Ltd | Polypeptide production |
JPS62177184A (ja) | 1986-01-29 | 1987-08-04 | Toyota Motor Corp | 鋳鉄製内燃機関用シリンダヘツドおよびその製造方法 |
JPH0775541B2 (ja) | 1986-06-07 | 1995-08-16 | 壽之 松尾 | C末端アミド化酵素及びその製造方法 |
EP0249477A3 (en) | 1986-06-12 | 1988-01-20 | Immunex Corporation | Functional recombinant analog polypeptides devoid of hydrophobic amino acids |
JP2598050B2 (ja) | 1987-07-17 | 1997-04-09 | サントリー株式会社 | C−末端α−アミド化酵素 |
US6255067B1 (en) | 1987-09-15 | 2001-07-03 | The Johns Hopkins University | cDNA encoding peptidyl-glycine alpha-amidating monooxygenase (PAM) |
JP2845468B2 (ja) | 1989-01-17 | 1999-01-13 | サントリー株式会社 | ヒト甲状腺由来C―末端α―アミド化酵素 |
-
1987
- 1987-08-14 US US07/086,161 patent/US6319685B1/en not_active Expired - Lifetime
-
1988
- 1988-08-09 HU HU884132A patent/HU213227B/hu unknown
- 1988-08-10 FI FI883722A patent/FI883722A/fi not_active Application Discontinuation
- 1988-08-11 DK DK198804489A patent/DK175538B1/da not_active IP Right Cessation
- 1988-08-12 NO NO88883592A patent/NO883592L/no unknown
- 1988-08-12 EP EP88307533A patent/EP0308067A3/en not_active Withdrawn
- 1988-08-12 DE DE3856446T patent/DE3856446T2/de not_active Expired - Lifetime
- 1988-08-12 EP EP92202879A patent/EP0529742B1/en not_active Expired - Lifetime
- 1988-08-12 RU SU884356445A patent/RU2080385C1/ru active
- 1988-08-12 AT AT92202879T patent/ATE198355T1/de not_active IP Right Cessation
- 1988-08-12 CA CA000574685A patent/CA1341454C/en not_active Expired - Lifetime
- 1988-08-12 RU RU96105702/13A patent/RU2252961C2/ru active
- 1988-08-13 KR KR1019880010344A patent/KR0136611B1/ko not_active IP Right Cessation
- 1988-08-15 JP JP63203037A patent/JP2979172B2/ja not_active Expired - Lifetime
-
1993
- 1993-12-21 LT LTIP1656A patent/LT4029B/lt not_active IP Right Cessation
-
1994
- 1994-07-01 HU HU94P/P00552P patent/HU212071A9/hu unknown
-
1995
- 1995-06-29 HU HU95P/P00552P patent/HU00552A9/hu unknown
Also Published As
Publication number | Publication date |
---|---|
EP0529742B1 (en) | 2000-12-27 |
LT4029B (en) | 1996-08-26 |
HU00552A9 (en) | 1995-10-30 |
EP0529742A1 (en) | 1993-03-03 |
HU212071A9 (en) | 1996-02-28 |
DK448988D0 (da) | 1988-08-11 |
JP2979172B2 (ja) | 1999-11-15 |
FI883722A0 (fi) | 1988-08-10 |
EP0308067A2 (en) | 1989-03-22 |
FI883722A (fi) | 1989-02-15 |
ATE198355T1 (de) | 2001-01-15 |
US6319685B1 (en) | 2001-11-20 |
RU2252961C2 (ru) | 2005-05-27 |
AU629795B2 (en) | 1992-10-15 |
DK448988A (da) | 1989-02-15 |
CA1341454C (en) | 2004-04-20 |
DE3856446D1 (de) | 2001-02-01 |
JPH02104281A (ja) | 1990-04-17 |
AU2057688A (en) | 1989-02-16 |
NO883592L (no) | 1989-02-15 |
KR0136611B1 (ko) | 1998-04-25 |
DE3856446T2 (de) | 2001-07-12 |
NO883592D0 (no) | 1988-08-12 |
RU2080385C1 (ru) | 1997-05-27 |
LTIP1656A (en) | 1995-07-25 |
EP0308067A3 (en) | 1989-07-26 |
HU213227B (en) | 1997-07-28 |
KR890003947A (ko) | 1989-04-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK175538B1 (da) | Fremgangsmåde til fremstilling af et alfa-amiderende enzym, genmanipuleret mikroorganisme eller værtscelle og rekombinant DNA-molekyle,............. | |
US5703207A (en) | Protein active in humoral hypercalcemia of malignancy-PTHrP | |
WO1992007068A1 (en) | Amyloidin protease and uses thereof | |
WO1988003170A1 (en) | Pulmonary hydrophobic surfactant-associated proteins | |
JPH07303482A (ja) | 新規なメタロプロテアーゼおよびそれをコードするdna | |
Yokoyama et al. | Porcine thyroid peroxidase: relationship between the native enzyme and an active, highly purified tryptic fragment | |
EP0588118B1 (en) | Bone-related carboxypeptidase-like protein and process for its production | |
EP0307513A2 (en) | Pulmonary hydrophobic surfactant-associated proteins | |
EP0580672B1 (en) | SYNTHETIC CDw52(CAMPATH-1) PEPTIDE ANTIGEN | |
CA1341535C (en) | Transforming growth factor peptides | |
AU2002339227A1 (en) | Triple polypeptide complexes | |
Randhawa et al. | Amino acid sequence of the serine active‐site region of the medium‐chain S‐acyl fatty acid synthetase thioester hydrolase from rat mammary gland | |
CA1338401C (en) | Anticoagulant polypeptide | |
JP2694604B2 (ja) | 新規なメタロプロテアーゼおよびそれをコードするdna | |
JP2003082422A (ja) | ガリウムの回収方法 | |
FI110433B (fi) | Alfa-amidointientsyymiä koodaava DNA-sekvenssi, isäntäsolu ja menetelmä amidoidun peptidien valmistamiseksi | |
WO1997049720A1 (en) | Recombinant fusion protein comprising pdc-e2, bcoadc-e2, and ogdc-e2 and uses thereof | |
JPH01231888A (ja) | アミド化酵素及びその製造方法 | |
CN114774395B (zh) | 肝病检测的高纯度壳多糖酶3样蛋白1抗原表位肽及制法 | |
JPH03163095A (ja) | ヒト神経成長因子の部分ペプチド、抗体およびその用途 | |
Powell | CHARACTERIZATION OF A NOVEL MESSENGER-RNA AND IMMUNOCHEMICAL DETECTION OF ITS PROTEIN FROM PORCINE GASTRIC MUCOSA | |
EP1130030A1 (en) | Human erythroid differentiation related factor | |
JP3868001B2 (ja) | ヒトmp52に対するモノクローナル抗体 | |
CN118027168A (zh) | 基于真核表达的msl重组植物蛋白的制备方法及用途 | |
JPH11103859A (ja) | 組み換え型ヒト肝癌細胞由来増殖因子、およびヒト肝癌細胞由来増殖因子を認識する抗体 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUP | Patent expired |